Sera Metabolomics Characterization of Patients at Different Stages in Wuhan Identifies Critical Biomarkers of COVID-19

Abstract

We have witnessed the 2-year-long global rampage of COVID-19 caused by the wide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, knowledge about biomarkers of the entire COVID-19 process is limited. Identification of the systemic features of COVID-19 will lead to critical biomarkers and therapeutic targets for early intervention and clinical disease course prediction. Here, we performed a comprehensive analysis of clinical measurements and serum metabolomics in 199 patients with different stages of COVID-19. In particular, our study is the first serum metabolomic analysis of critical rehabilitation patients and critical death patients. We found many differential metabolites in the comparison of metabolomic results between ordinary, severe, and critical patients and uninfected patients. Through the metabolomic results of COVID-19 patients in various stages, and critical rehabilitation patients and critical death patients, we identified a series of differential metabolites as biomarkers, a separate queue and precise distinction, and predicted COVID-19 verification. These differentially expressed metabolites, included 1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate, propylparaben, 20-hydroxyeicosatetraenoic acid, triethanolamine, chavicol, disialosyl galactosyl globoside, 1-arachidonoylglycerophosphoinositol, and alpha-methylstyrene, all of which have been identified for the first time as biomarkers in COVID-19 progression. These biomarkers are involved in many pathological and physiological pathways of COVID-19, for example, immune responses, platelet degranulation, and metabolism which might result in pathogenesis. Our results showed valuable information about metabolites obviously altered in COVID-19 patients with different stages, which could shed light on the pathogenesis as well as serve as potential therapeutic agents of COVID-19.

Untargeted metabolomics reveals dynamic changes in metabolic profiles of rat supraspinatus tendon at three different time points after diabetes induction

“…Metabolomics techniques involve the identification and characterization of small molecules; the commonly used analytical techniques include nuclear magnetic resonance (NMR), gas chromatography-mass spectrometry (GC-MS), and liquid chromatography-mass spectrometry (LC-MS) ( 21 ). Non-targeted metabolomics studies analyze endogenous small molecule metabolites in the body without bias, providing information on thousands of compounds detected in samples and discovering the correlation between metabolites and physiological and pathological changes ( 22 ). Because each individual’s metabolic profile is unique, fluctuations and differences in metabolite levels directly reflect the mechanisms underlying disease development and progression ( 23 ).…”

Respiratory Effects of Traffic-Related Air Pollution: A Randomized, Crossover Analysis of Lung Function, Airway Metabolome, and Biomarkers of Airway Injury

“…The detailed description on LC-MS/MS analysis can be found elsewhere. 29 In brief, LC-MS/MS analyses were performed using an UHPLC system (Vanquish; Thermo Fisher Scientific) with a UPLC BEH Amide column ( , ) coupled to a Q Exactive HF-X (QE HFX) mass spectrometer (Orbitrap MS; Thermo). The QE HFX mass spectrometer was used owing to its ability to acquire MS/MS spectra in information-dependent acquisition mode in the control of the acquisition software (Xcalibur; Thermo).…”

Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification

“…Untargeted metabolomics revealed that lipids including PC (30:2) and PC (30:1) as biomarkers of prognosis play a key role in discriminating early hepatocellular carcinoma and compensated cirrhosis [78]. Lactate was identified as an essential molecule and reinforced Treg cells in the tumor microenvironment via lactylation [79]. The circulating level of gut microbe-generated metabolite trimethylamine N-oxide (TMAO) was associated with the risks of various cardiovascular diseases and can be used as a mediator biomarker for monitoring the severity and prognosis of atherosclerotic vascular disease [80].…”